We found that both Smoi and Runx1i had significant effects on organoid growth, and together, the inhibitors did not display synergism, suggesting that Runx1 acts positively on BCC growth through the same downstream mechanism (Fig. 3j, k, Supplementary Fig. 4a). The gene discussed is RUNX1; the disease is skin basal cell carcinoma.